What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cardiology
Samuel Z. Goldhaber mostly deals with Pulmonary embolism, Surgery, Internal medicine, Thrombosis and Cardiology.
His Pulmonary embolism research is multidisciplinary, incorporating perspectives in Respiratory disease, Embolism, Thrombolysis, Radiology and Vascular disease.
Samuel Z. Goldhaber has included themes like Plasminogen activator, Anesthesia and Tissue plasminogen activator in his Surgery study.
Within one scientific family, he focuses on topics pertaining to Mortality rate under Thrombosis, and may sometimes address concerns connected to Hazard ratio.
His research investigates the connection between Cardiology and topics such as Blood pressure that intersect with problems in Autopsy.
His research in Venous thrombosis tackles topics such as Intensive care medicine which are related to areas like Anticoagulant, Venous thromboembolic disease and Evidence-based medicine.
His most cited work include:
- Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (5057 citations)
- Acute pulmonary embolism: clinical outcomes in the international cooperative pulmonary embolism registry (ICOPER) (2198 citations)
- Dabigatran versus warfarin in the treatment of acute venous thromboembolism (1935 citations)
What are the main themes of his work throughout his whole career to date?
Samuel Z. Goldhaber mainly investigates Pulmonary embolism, Internal medicine, Surgery, Cardiology and Thrombosis.
His Pulmonary embolism study combines topics from a wide range of disciplines, such as Respiratory disease, Thrombolysis, Intensive care medicine, Radiology and Venous thrombosis.
His studies deal with areas such as Venous thromboembolism and Disease as well as Intensive care medicine.
In his research on the topic of Surgery, Anesthesia is strongly related with Warfarin.
When carried out as part of a general Cardiology research project, his work on Heart failure and Coronary artery disease is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
His work carried out in the field of Thrombosis brings together such families of science as Anticoagulant, Thrombus, Vascular disease and Heparin.
He most often published in these fields:
- Pulmonary embolism (46.31%)
- Internal medicine (45.53%)
- Surgery (29.33%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (45.53%)
- Pulmonary embolism (46.31%)
- Thrombosis (22.49%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Pulmonary embolism, Thrombosis, Venous thromboembolism and Cardiology.
His Atrial fibrillation, Stroke, Randomized controlled trial and Anticoagulant study, which is part of a larger body of work in Internal medicine, is frequently linked to In patient, bridging the gap between disciplines.
His Pulmonary embolism research focuses on Ultrasound and how it connects with Catheter.
His Thrombosis study combines topics in areas such as Thrombolysis, Confidence interval and Intensive care medicine.
While the research belongs to areas of Intensive care medicine, Samuel Z. Goldhaber spends his time largely on the problem of Rivaroxaban, intersecting his research to questions surrounding Placebo.
His Deep vein research entails a greater understanding of Surgery.
Between 2017 and 2021, his most popular works were:
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up (1132 citations)
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up (1132 citations)
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events (402 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
Samuel Z. Goldhaber spends much of his time researching Internal medicine, Stroke, Thrombosis, Pulmonary embolism and Atrial fibrillation.
His studies link Cardiology with Internal medicine.
His Stroke research includes themes of Prospective cohort study, Cohort study, Bleed and Comorbidity.
His Thrombosis study incorporates themes from Randomized controlled trial, Intensive care medicine, Heparin and Antithrombotic.
Samuel Z. Goldhaber brings together Pulmonary embolism and Vital registration to produce work in his papers.
His Deep vein study introduces a deeper knowledge of Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
